Hologic Inc. (NASDAQ:HOLX) issued an update on its first quarter earnings guidance on Monday morning. The company provided EPS guidance of $0.30-0.31 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.40, ARN reports. The company issued revenue guidance of $600-610 million, compared to the consensus revenue estimate of $646.62 million.Hologic also updated its FY14 guidance to $1.32-1.38 EPS.
HOLX has been the subject of a number of recent research reports. Analysts at Citigroup Inc. downgraded shares of Hologic from a buy rating to a neutral rating in a research note to investors on Wednesday, October 16th. They now have a $24.00 price target on the stock. On a related note, analysts at Needham & Company initiated coverage on shares of Hologic in a research note to investors on Wednesday, October 2nd. They set a buy rating and a $26.00 price target on the stock. Finally, analysts at Ned Davis Research downgraded shares of Hologic from a neutral rating to a sell rating in a research note to investors on Monday, September 30th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating, five have assigned a buy rating and two have issued a strong buy rating to the stock. The stock currently has an average rating of Hold and an average price target of $23.88.
Hologic Inc. (NASDAQ:HOLX) opened at 22.899 on Tuesday. Hologic Inc. has a 52-week low of $18.46 and a 52-week high of $23.96. The stock’s 50-day moving average is $21.69 and its 200-day moving average is $21.20. The company’s market cap is $6.193 billion.
Hologic (NASDAQ:HOLX) last released its earnings data on Monday, November 11th. The company reported $0.39 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.37 by $0.02. The company had revenue of $622.10 million for the quarter, compared to the consensus estimate of $624.40 million. During the same quarter in the previous year, the company posted $0.37 earnings per share. The company’s revenue for the quarter was up 3.6% on a year-over-year basis. On average, analysts predict that Hologic Inc. will post $1.48 earnings per share for the current fiscal year.
In other Hologic news, CFO Glenn P. Muir sold 140,000 shares of the stock on the open market in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $22.32, for a total transaction of $3,124,800.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products to serving the healthcare needs of women.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.